Image-guided therapy took a step forward May 20 with the introduction by Nomos of an ultrasound real-time imaging/positioning technology called ImageSync. Built into Nomos' new BAT SXi image-guided therapy technology, ImageSync provides a stream of
Image-guided therapy took a step forward May 20 with the introduction by Nomos of an ultrasound real-time imaging/positioning technology called ImageSync. Built into Nomos' new BAT SXi image-guided therapy technology, ImageSync provides a stream of ultrasound images that can be utilized in real-time to localize cancer targets prior to radiation therapy. Clinicians and therapists can dynamically move and align structure sets with the touch of a finger. The new technology is compatible with conventional radiotherapy as well as intensity-modulated radiation therapy.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.